共 7 条
- [1] A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trialJOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 27 (04) : 359 - 364Morrow, David A.Brickman, Chaim M.Murphy, Sabina A.Baran, KennethKrakover, RicardoDauerman, HaroldKumar, SujathaSlomowitz, NatanyaGrip, LauraMcCabe, Carolyn H.Salzman, Andrew L.
- [2] A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trialJournal of Thrombosis and Thrombolysis, 2009, 27 : 359 - 364David A. MorrowChaim M. BrickmanSabina A. MurphyKenneth BaranRicardo KrakoverHarold DauermanSujatha KumarNatanya SlomowitzLaura GripCarolyn H. McCabeAndrew L. Salzman
- [3] Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical TrialFRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8Huang, DongQian, JuyingLiu, ZongjunXu, YaweiZhao, XianxianQiao, ZengyongFang, WeiyiJiang, LiHu, WeiShen, ChengxingLiang, ChunZhang, QiGe, Junbo
- [4] Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker Administration before primary PCI in patients with ST-elevation Myocardial Infarction trialAMERICAN HEART JOURNAL, 2014, 168 (05) : 661 - 666Roolvink, VincentRasoul, SamanOttervanger, Jan PaulDambrink, Jan-Henk E.Lipsic, Erikvan der Horst, Iwan C. C.de Smet, BartKedhi, ElvinGosselink, A. T. MarcelPiek, Jan J.Sanchez-Brunete, VicenteIbanez, BorjaFuster, Valentinvan't Hof, Arnoud W. J.
- [5] Randomized, Double-Blind, Placebo-Controlled, Single Intravenous Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of the Novel Coronary Smooth Muscle Cell Proliferation Inhibitor Biolimus A9 in Healthy IndividualsJOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01): : 29 - 39Steudel, WolfgangDingmann, ColleenZhang, Yan-LingBendrick-Peart, JamieClavijo, ClaudiaShulze, JohnBetts, RonaldChristians, Uwe
- [6] Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarctionAMERICAN HEART JOURNAL, 2013, 165 (04) : 509 - +Chakrabarti, Anjan K.Feeney, KristinAbueg, CassandraBrown, David A.Czyz, EwaTendera, MichalAndras JanosiGiugliano, Robert P.Kloner, Robert A.Weaver, W. DouglasBode, ChristophGodlewski, JacekBela MerkelyGibson, C. Michael
- [7] Impact of High-Dose N-Acetylcysteine Versus Placebo on Contrast-Induced Nephropathy and Myocardial Reperfusion Injury in Unselected Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (20) : 2201 - 2209Thiele, HolgerHildebrand, LysannSchirdewahn, CarmenEitel, IngoAdams, VolkerFuernau, GeorgErbs, SandraLinke, AxelDiederich, Klaus-WernerNowak, MarekDesch, SteffenGutberlet, MatthiasSchuler, Gerhard